Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

Aspirin Use Tied to Slower AAA Progression

Todd Neale

December 20, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

Shelley Wood

August 02, 2021

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Caitlin E. Cox

June 14, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Daily News

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Todd Neale

March 08, 2021

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Daily News

PAD Patients Undertreated With Statins Despite Elevated CV Risk

L.A. McKeown

July 13, 2020

Advertisement

December 2025 Dispatch for the CV Team

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

January 2024 Dispatch for the CV Team

Aspirin Use Tied to Slower AAA Progression

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Only Half of Revascularized PAD Patients Receive GDMT

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

September 2021 News Roundup

TCTMD’s Top 10 Most Popular Stories for July 2021

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

May 2021 News Roundup

ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

PAD Patients Undertreated With Statins Despite Elevated CV Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content